The primary drug created only by artificial intelligence (AI) without human intervention enters clinical trials.
CNBC reported on the twenty ninth (local time) that Insilico Medicine, a biotechnology startup in Hong Kong, has developed...
Bloomberg reported on the twenty sixth (local time) that Neuralink, a brain-computer connection technology (BCI) company, has received approval from the US Food and Drug Administration (FDA) for human clinical trials.
In keeping with this,...
We’re excited to announce that Dr. Tim Miller, assistant professor on the Harvard Medical School (link), and college member within the Computational Health Informatics Program (link) at Boston Children’s Hospital, has joined the Lavita...
In my view crucial thing is to not be afraid of truly attending to that diffuse and scale step. , albeit in a shadow mode. Only after making that step are you able to...